Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes-Reference-Cited by-同舟云学术

Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

Published:2011 Issue:2 Volume:14 Page:140
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Lee Yu Rim¹,Huh Seok Jae¹,Lee Dong Hyun¹,Yoon Hyun Hwa¹,Seol Young-Mi²,Choi Young-Jin²,Kwon Kyung A¹,Lee Suee¹,Oh Sung Yong¹³,Kim Sung-Hyun¹,Kim Hyo-Jin¹,Kwon Hyuk-Chan¹³

Affiliation:

1. Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.

2. Department of Internal Medicine, Pusan National University Hospital Medical Research Institute, Pusan National University School of Medicine, Busan, Korea.

3. Medical Research Center for Cancer Molecular Therapy, Dong-A University College of Medicine, Busan, Korea.

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2011.14.2.140

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of peroral form of vinorelbine in metastatic breast cancer – choice in favor of quality of life;Medical alphabet;2022-07-26

2. Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals;Cancers;2022-04-24

3. Fever and breast cancer: A critical review of the literature and possible underlying mechanisms;Breast Disease;2021-07-15

4. HER2-Positive Breast Cancer;Her2-Positive Breast Cancer;2019

5. Neuropathies périphériques chimio-induites : symptomatologie et épidémiologie;Bulletin du Cancer;2018-11